Stem Cell Therapy
What is Stem Cell Therapy?
Stem cell therapy is a type of regenerative medicine that utilizes stem cells to treat or prevent diseases and conditions. Stem cells are unique cells in the body that have the ability to develop into different types of cells and have the potential to repair or replace damaged tissues and organs. This therapy is being explored for a wide range of conditions, including neurodegenerative disorders, spinal cord injuries, heart disease, and certain types of cancer. Types include embryonic stem cells, adult stem cells (found in bone marrow and other tissues), and induced pluripotent stem cells (iPSCs) — adult cells reprogrammed to an embryonic-like state.
Indications
Stem cell therapy is indicated or being investigated for the following conditions:
- Blood disorders such as leukemia, lymphoma, and aplastic anemia (via hematopoietic stem cell transplantation)
- Neurodegenerative disorders such as Parkinson's and Alzheimer's disease
- Spinal cord injuries
- Heart disease and cardiac repair
- Diabetes and metabolic disorders
Who needs stem cell therapy?
Patients with conditions where conventional treatments have failed or are insufficient may benefit from stem cell therapy:
- Hematological cancers: Leukemia, lymphoma, and myeloma treated via stem cell transplantation.
- Neurodegenerative diseases: Conditions like Parkinson's where dopamine-producing cells are lost.
- Autoimmune diseases: Severe autoimmune conditions unresponsive to standard therapy.
- Spinal cord injuries: Injuries causing partial or complete paralysis.
Other conditions that may require Stem Cell Therapy include: Osteoarthritis and joint disease, Diabetes type 1, Heart failure (investigational), Multiple sclerosis (in clinical trials).
Many stem cell therapies are still in experimental stages. It is essential to engage with accredited centers conducting evidence-based treatments and clinical trials.
Who can donate stem cells?
Stem cells can be sourced from the patient (autologous) or a donor (allogeneic). Donors may be matched siblings, unrelated matched donors, or umbilical cord blood banks. Donors must pass HLA matching and comprehensive health screening.
Eligibility requirements
- Confirmed diagnosis of a condition treatable by stem cell therapy
- Adequate organ function to tolerate the procedure
- No active uncontrolled infections
- No active cancer (for allogeneic donors)
- Compatible HLA type with the recipient (for allogeneic transplants)
- Psychological readiness and informed consent
Evaluation process
Patients undergo a full medical workup including blood tests, imaging, and disease-specific assessments. For allogeneic transplants, HLA typing is performed for both donor and recipient. The multidisciplinary team designs an individualized treatment protocol.
What are our services?
We are offering the following specialized services to all patients at renowned hospitals in India and Türkiye. Our organization is proudly partnered with multiple accredited hospitals across both countries, known for their strong reputations, state-of-the-art infrastructure, and patient-centric approach.
These hospitals provide a world-class healthcare environment with excellent ambience, comprehensive diagnostic and treatment facilities, and strict infection control protocols. Each center is equipped with advanced medical technology and a highly skilled multidisciplinary team capable of managing even the most complex cases. With a strong track record of successful outcomes, these hospitals ensure quality care at every step of the patient journey — from pre-treatment evaluation and surgery to post-operative care and long-term follow-up.